Chengyuan Fang

150# Haping Road
Harbin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Engineered Lactate Catabolizing Probiotics Reveal Timescale Dependent Microbiome-Host Metabolic Coupling.

Engineered Lactate Catabolizing Probiotics Reveal Timescale Dependent Microbiome-Host Metabolic Coupling.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026

Divergent neuropsychiatric and systemic toxicity profiles of abemaciclib and palbociclib: a triangulation study integrating pharmacovigilance, genetic epidemiology, and multi-omics profiling.

Divergent neuropsychiatric and systemic toxicity profiles of abemaciclib and palbociclib: a triangulation study integrating pharmacovigilance, genetic epidemiology, and multi-omics profiling.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 08, 2026

Publisher Correction: Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut.

Publisher Correction: Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut.

Journal: Nature microbiology
Published: December 23, 2025

Programmable conjugative CRISPR interference targeting genotoxin in the gut.

Programmable conjugative CRISPR interference targeting genotoxin in the gut.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Programmable conjugative CRISPR interference targeting genotoxin in the gut.

Programmable conjugative CRISPR interference targeting genotoxin in the gut.

Journal: Research square
Published: November 24, 2025

Preoperative conversion therapy of camrelizumab combined with paclitaxel and nedaplatin for unresectable advanced esophageal squamous cell carcinoma: a phase 2 study.

Preoperative conversion therapy of camrelizumab combined with paclitaxel and nedaplatin for unresectable advanced esophageal squamous cell carcinoma: a phase 2 study.

Journal: BMC medicine
Published: October 30, 2025

Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut.

Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut.

Journal: Nature microbiology
Published: January 16, 2025

Factors linked to lung cancer in MIMIC-IV database.

Factors linked to lung cancer in MIMIC-IV database.

Journal: Journal of thoracic disease
Published: November 18, 2024

A comprehensive prognostic and immunological implications of PFKP in pan-cancer.

A comprehensive prognostic and immunological implications of PFKP in pan-cancer.

Journal: Cancer cell international
Published: June 03, 2024

Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study).

Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study).

Journal: International journal of surgery (London, England)
Published: September 13, 2023

Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation.

Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation.

Journal: American journal of physiology. Cell physiology
Published: August 14, 2023

Nucleoporin 93, a new substrate of the E3 ubiquitin protein ligase HECTD1, promotes esophageal squamous cell carcinoma progression.

Nucleoporin 93, a new substrate of the E3 ubiquitin protein ligase HECTD1, promotes esophageal squamous cell carcinoma progression.

Journal: Human cell
Published: July 30, 2023
Showing 1-12 of 20

Last Updated: 09/26/2026